Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M639Revenue $M51.3Net Margin (%)-47.2Altman Z-Score11.1
Enterprise Value $M443EPS $-0.4Operating Margin %-49.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.1Pre-tax Margin (%)-48.6Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %-2.7Quick Ratio10.2Cash flow > EarningsY
Price/Sales12.35-y EBITDA Growth Rate %-4.7Current Ratio10.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-9.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-11.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M69.5ROIC % (ttm)-110.3Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOJoel Greenblatt 2015-03-31 Sold Out -0.0021%$12.64 - $18.54
($15.47)
$ 9.19-41%Sold Out0
SGMOJoel Greenblatt 2014-12-31 Buy $9.85 - $16.53
($12.15)
$ 9.19-24%New holding17,441
SGMOFirst Eagle Investment 2014-06-30 Add0.01%$11.71 - $17.95
($14.37)
$ 9.19-36%Add 34.10%536,380
SGMOFirst Eagle Investment 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 9.19-52%Reduce 52.81%400,000
SGMOFirst Eagle Investment 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 9.19-8%Add 99.73%847,550
SGMOFirst Eagle Investment 2013-06-30 Add$7.31 - $10.65
($8.72)
$ 9.195%Add 41.45%424,350
SGMOFirst Eagle Investment 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 9.193%New holding300,000
SGMOFirst Eagle Investment 2010-03-31 Sold Out $4.76 - $6.63
($5.63)
$ 9.1963%Sold Out0
SGMOFirst Eagle Investment 2009-12-31 Buy $5.04 - $8.09
($5.87)
$ 9.1957%New holding470
SGMOFirst Eagle Investment 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.32)
$ 9.1945%Sold Out0
SGMOFirst Eagle Investment 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 9.19119%New holding260,600
SGMOFirst Eagle Investment 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 9.19124%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2015-07-15Sell25,000$10.43-11.89view
Wolff Henry WardExec VP & CFO 2015-07-13Sell12,000$10-8.1view
LANPHIER EDWARD O IIPresident & CEO 2015-06-15Sell25,000$11.08-17.06view
Wolff Henry WardExec VP & CFO 2015-06-10Sell12,000$12.21-24.73view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-06-05Sell15,000$12.29-25.22view
RINGO WILLIAM RDirector 2015-06-03Sell2,200$12.44-26.13view
Gregory Philip DSVP of Research & CSO 2015-06-01Sell15,000$12.39-25.83view
LANPHIER EDWARD O IIPresident & CEO 2015-05-15Sell25,000$11.51-20.16view
Wolff Henry WardExec VP & CFO 2015-05-11Sell12,000$13.25-30.64view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-05-05Sell15,000$12.29-25.22view

Quarterly/Annual Reports about SGMO:

News about SGMO:

Articles On GuruFocus.com
Biogen or Bluebird: Which Will Lead in SCD? Apr 30 2015 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 
Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results Feb 04 2009 

More From Other Websites
Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference Aug 04 2015
Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference Aug 04 2015
Shire Plc Earnings Q2*, 2015 Aug 04 2015
Biogen, Inc. Earnings Analysis: By the Numbers Q2*, 2015 Aug 03 2015
Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast Jul 29 2015
Sangamo BioSciences Announces Second Quarter 2015 Conference Call and Webcast Jul 29 2015
SANGAMO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 25 2015
Sangamo BioSciences Announces Presentation At The 2015 JMP Securities Life Sciences Conference Jun 17 2015
Sangamo BioSciences Announces Presentation At The 2015 JMP Securities Life Sciences Conference Jun 17 2015
Bluebird Bio Gets Wall Street Love For Drug Results Jun 15 2015
Wednesday's After-Hours Movers: Five Below, FireEye And More Jun 03 2015
SANGAMO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 03 2015
MKM Partners' 4 Health Care Stocks to Sell Before June May 27 2015
Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference May 26 2015
Sangamo BioSciences Announces Presentation At The Jefferies 2015 Global Healthcare Conference May 26 2015
Sangamo BioSciences Presents New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storge... May 18 2015
Sangamo BioSciences Presents New Data from Proprietary ZFP Therapeutic Programs for Lysosomal Storge... May 18 2015
Sangamo BioSciences Provides Clinical Update On SB-728-T Program and Developments In Other ZFP... May 14 2015
Sangamo BioSciences Provides Clinical Update On SB-728-T Program and Developments In Other ZFP... May 14 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK